| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702326 | Surgical Oncology | 2017 | 13 Pages |
Abstract
Low expression of (or IHC-negative) COX2, miR-200c, ERCC1 and TS, or high expression of (or IHC-positive) CDC25B and p16 are potential biomarkers for predicting the response of esophageal cancer patients treated with chemo(radio)therapy.
Keywords
NSEJWACYFRA21-1AFAP1-AS1SMACPitx2p53R2P-gpIGFBP-3MRP-1ESCCp-mTORBcl-2Insulin-like growth factor-binding protein-3CeAP-glycoproteinAdenocarcinomacarcinoembryonic antigenBaxPredictive biomarkersThymidine phosphorylaseShhSecond mitochondria-derived activator of caspaseEsophageal cancerthymidylate synthasesonic hedgehogPaired-like homeodomain transcription factor 2Meta-analysisB-cell lymphoma 2Bcl-2-associated X proteinEsophageal squamous cell carcinoma
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yang Li, He-Cheng Huang, Long-Qi Chen, Li-Yan Xu, En-Min Li, Jian-Jun Zhang,